Skip to content
  • Facebook
  • LinkedIn
  • Bluesky
  • YouTube
ERN-RND | European Reference Network on Rare Neurological Diseases

ERN-RND | European Reference Network on Rare Neurological Diseases

for rare or low prevalence complex diseases

Members Area
  • Home
  • About us
    • What is an ERN
    • Cross border healthcare
    • What is ERN-RND
    • Objectives of ERN-RND
    • Diseases Groups Covered
    • ERN-RND coordinators
    • ERN-RND coordination office
    • ERN-RND board
    • Patient advocates
    • Work Packages
    • Monitoring
    • Publications Acknowledging ERN-RND
  • Expert Centres
    • … for rare neurological diseases
    • Full members and affiliated partners
    • How to contact expert centres
    • Supporting partners
    • Map of expert centers
    • Overview ERNs
  • Online case discussion with CPMS
    • What is the CPMS
    • Who can use it
    • How to use it
    • MLD Treatment eligibility panel
    • Neuroradiology Expert Advice Panel
    • Multidisciplinary Board for DBS in Dystonia
    • CPMS Helpdesk
    • Videos
    • Downloads
    • Websites
  • Disease Knowledge
    • Cerebellar Ataxia & Hereditary Spastic Paraplegias (HSPs)
    • Chorea & Huntington’s disease
    • Dystonias, NBIA and Paroxysmal Disorders
    • Frontotemporal dementia
    • Leukoencephalopathies
    • Atypical Parkinsonism: MSA, PSP & Genetic Parkinson’s Disease
    • ERN-RND Patient Journeys
  • Education & Training
    • Online Medical Education
    • Upcoming Webinars
    • Training Resources
    • Webinars from Partners
    • Winter School
  • ERN-RND Registry
    • ERN-RND registry objectives
    • Disease Groups covered
    • Data Submission
      • Data Analysis
    • Data Access
    • Contact
  • Collab­ora­tions
    • Projects
    • Partner organisations
    • Past projects
      • EJP RD
        • EJP RD in a nutshell
        • What is EJP RD?
        • EJP RD mission & goals
        • EJP RD & ERNs
      • Solve-RD
        • What is Solve-RD?
        • Main Objectives
        • Implementation Steps
        • Analysis
      • Value of Treatment (VoT) project
        • VoT project coordinator
        • Objectives of the VoT project
        • ERN-RND in VoT2
        • Academic partners in VoT2
        • Further reading
  • News & Events
    • News
    • Events
    • Newsletter
    • Meet the members
  • Contact us
  • Facebook
  • LinkedIn
  • Bluesky
  • YouTube

Domain: Diagnosis/Neurogenetics

Biofluid biomarkers in atypical parkinsonism

Biofluid biomarkers in atypical parkinsonism

21 Jun. 2022

Speaker: Per Svenningsson
Karolinska University Hospital, Stockholm, Sweden

Recording

Basal ganglia diseases in childhood

Basal ganglia diseases in childhood

12 Apr. 2022

Speaker: Belén Perez Dueñas
Vall d’Hebron University Hospital, Barcelona, Spain

Slides

The logopenic variant of primary progressive aphasia (lvPPA): language, cognitive, neuroradiological issues’

The logopenic variant of primary progressive aphasia (lvPPA): language, cognitive, neuroradiological issues’

5 Apr. 2022

Speaker: Robert Rusina & Zsolt Cséfalvay
Thomayer Hospital, Prague, Czech Republic; Comenius University in Bratislava, Slovakia

Slides

Measuring disease severity in chronic progressive myelopathy

Measuring disease severity in chronic progressive myelopathy

15 Mar. 2022

Speaker: Marc Engelen
VU University Medical Center Amsterdam, Netherlands

Recording

Slides

Brain Development in Huntington’s Disease

Brain Development in Huntington’s Disease

8 Mar. 2022

Speaker: Peggy Nopoulos
Carver College of Medicine, University of Iowa, USA

Recording

Slides

New MDS criteria for clinical diagnosis of MSA

New MDS criteria for clinical diagnosis of MSA

15 Feb. 2022

Speaker: Gregor Wenning & Iva Stankovic
Medical University Innsbruck, Austria; University of Belgrade, Serbia

Recording

The overlap between the spectrum of frontotemporal dementias and atypical Parkinsonism

The overlap between the spectrum of frontotemporal dementias and atypical Parkinsonism

8 Feb. 2022

Speaker: Vasilios Constantinides
National and Kapodistrian University of Athens, Greece.

Recording

Slides

Clinical outcome assessments in Ataxias

Clinical outcome assessments in Ataxias

9 Nov. 2021

Speaker: Thomas Klockgether
University Hospital Bonn, Germany

Slides

Pelizaeus-Merzbacher disease and related disorders (pediatric focus)

Pelizaeus-Merzbacher disease and related disorders (pediatric focus)

26 Oct. 2021

Speaker: Nicole Wolf
VU University Medical Center Amsterdam, Netherlands;
Emma Children’s Hospital, Amsterdam, Netherlands

Slides

Functional gait disorders: a sign-based approach

Functional gait disorders: a sign-based approach

12 Oct. 2021

Speaker: Jorik Nonnekes
Radboud University Medical Centre, Nijmegen, Netherlands

Recording

Slides

X-Linked leukodystrophies – Update

X-Linked leukodystrophies – Update

7 Oct. 2021

Speaker: Caroline Sevin
Reference Center for Leukodystrophies, Hôpital de Bicêtre and ICM (institute of Brain and Spine), Paris, France

Recording

Slides

Adult leukodystrophies/early symptoms of late-onset Leukodystrophies

Adult leukodystrophies/early symptoms of late-onset Leukodystrophies

5 Oct. 2021

Speaker: Fanny Mochel
APHP – Pitié-Salpêtrière Hospital, Paris, France

Recording

Slides

Treatable dystonia &dystonia in inborn errors of metabolism

Treatable dystonia &dystonia in inborn errors of metabolism

28 Sep. 2021

Speaker: Tom J. de Koning
University Medical Centre Groningen, Netherlands

Recording

Slides

Genetic forms of parkinson

Genetic forms of parkinson

14 Sep. 2021

Speaker: Thomas Gasser
University Hospital Tübingen, Germany

Recording

Slides

Speech as a biomarker in ataxia: What can it tell us and how should we use it?

Speech as a biomarker in ataxia: What can it tell us and how should we use it?

6 Jul. 2021

Speaker: Adam Vogel
University of Melbourne, Australia

Recording

Metachromatic Leukodystrophy – update

Metachromatic Leukodystrophy – update

15 Jun. 2021

Speaker: Samuel Gröschel & Ingeborg Krägeloh
University Hospital Tübingen, Germany

Slides

MRI pattern recognition in leukodystrophies

MRI pattern recognition in leukodystrophies

8 Jun. 2021

Speaker: Nicole Wolf
VU University Medical Center Amsterdam, Netherlands;
Emma Children’s Hospital, Amsterdam, Netherlands

Slides

Better Conversations – Communication Partner Training for language led dementias

Better Conversations – Communication Partner Training for language led dementias

18 May 2021

Speaker: Kathryn Peall
Neurosciences and Mental Health Research Institute, Cardiff, United Kingdom

Recording

Approach to the patient with non-HD chorea

Approach to the patient with non-HD chorea

20 Apr. 2021

Speaker: Ruth Walker
James J. Peters Veterans Affairs Medical Center, New York City, USA
Department of Neurology, Mount Sinai School of Medicine, New York City, USA

Slides

MR Biomarkers in Spinocerebellar Ataxias

MR Biomarkers in Spinocerebellar Ataxias

13 Apr. 2021

Speaker: Gülin Öz
University of Minnesota, USA

Recording

Challenges in Frontotemporal Dementia: clinical, genetic and pathological heterogeneity

Challenges in Frontotemporal Dementia: clinical, genetic and pathological heterogeneity

23 Mar. 2021

Speaker: Harro Seelaar
Erasmus University Medical Center, Rotterdam, Netherlands

Recording

Genetic dystonia and treatment

Genetic dystonia and treatment

2 Feb. 2021

Speaker: Sylvia Boesch
Medical University Innsbruck, Austria

Slides

Progressive Supranuclear Palsy – Update on Diagnostics, Biomarkers, Therapies

Progressive Supranuclear Palsy – Update on Diagnostics, Biomarkers, Therapies

26 Jan. 2021

Speaker: Günter Höglinger
Hannover Medical School, Germany

Recording

Slides

Development of Sara-home: a novel assessment tool for patients with ataxia.

Development of Sara-home: a novel assessment tool for patients with ataxia.

24 Nov. 2020

Speaker: Gessica Vasco & Susanna Summa
Pediatric Hospital Bambino Gesù, Rome, Italy

Recording

Slides

Diagnostic algorithm for childhood onset chorea

Diagnostic algorithm for childhood onset chorea

13 Oct. 2020

Speaker: Juan Dario Ortigoza Escobar
Sant Joan de Déu Hospital, Barcelona, Spain

Recording

Slides

A challenge in neurogenetics: Huntington disease in kids

A challenge in neurogenetics: Huntington disease in kids

15 Sep. 2020

Speaker: Ferdinando Squitieri
IRCCS – CSS-Mendel Institute, Rome, Italy

Recording

Slides

How to assess and manage spastic gait in rare diseases

How to assess and manage spastic gait in rare diseases

10 Sep. 2020

Speaker: Gál Ota
Charles University and General University Hospital, Prague, Czech Republic

Recording

Slides

Semantic variant of primary progressive aphasia

Semantic variant of primary progressive aphasia

8 Sep. 2020

Speaker: Robert Rusina
Thomayer Hospital, Prague, Czech Republic

Recording

Slides

Primary progressive aphasia subtyping in clinical practice

Primary progressive aphasia subtyping in clinical practice

26 May. 2020

Speaker: Rik Vandeberghe
University Hospital Leuven, Belgium

Recording

Slides

Paroxysmal dyskinesias: update on clinical and genetic aspects

Paroxysmal dyskinesias: update on clinical and genetic aspects

12 May. 2020

Speaker: Giovanna Zorzi
IRCCS – Foundation of the Carlo Besta Neurological Institute, Milan, Italy

Recording

Slides

Posts pagination

Previous page Page 1 Page 2 Page 3 Next page

Webinar Schedule

Find us on Bluesky

ERN-RND

@ern-rnd.bsky.social

172 Followers 90 Following 215 Posts

European Reference Network for Rare Neurological Diseases (ERN-RND) to improve diagnosis, care & treatment of RND patients.
Free webinars: https://www.ern-rnd.eu/education-training/online-medical-education-for-rare-neurological-diseases/

  • Get to this post

    ERN-RND @ern-rnd.bsky.social 2 days

    💻 Upcoming #webinar on “The importance of Genetic Counselling in the Diagnostic of Rare Neurological Disorders”
    📅 9th December
    ⚠️Updated time: now at 1 PM CET.
    🗣️ Maria Judit Molnar, Semmelweis University, Budapest, Hungary
    Sign up 👉https://t1p.de/d825https://t1p.de/d825hps://bsky.app/hashtag/webinar">#webinar and
  • Get to this post

    ERN-RND @ern-rnd.bsky.social 2 days

    One last time #RareNeurologicalDisease news and events in 2025! Stay up to date with the latest developments in rare neurological disorders — including #HuntingtonDisease, #HSP, #Dystonia, #MSA, #Leukodystrophies, #FrontotemporalDementia — with our monthly newsletter: https://f.mtr.cool/nvtixiqcex
  • Get to this post

    ERN-RND @ern-rnd.bsky.social 3 days

    Join us for this "High Level Meeting on a European Innovation and Care Ecosystem for Rare and Complex Diseases" on December 9-12, 2025 - remotely. More information: www.brains4brain.eu/eu-activitie...
  • Get to this post

    ERN-RND @ern-rnd.bsky.social 3 days

    Children with GNAO1-related disorders often face developmental delays and challenging movement disorders. For some, #DeePBrainStimulation can be a life-changing intervention. To support parents during this process, our members at Hospital #DeePBrainStimulation createdinformation flyers. #GNAO1
  • Get to this post

    ERN-RND @ern-rnd.bsky.social 3 days

    📢 !NEW TIME!
    👉 Our free webinar with Maria Judit Molnar on #GeneticCounselling for #RareNeurologicalDiseases next week will be at 1pm CET instead of the usual time at 3 pm.
    If you haven't registered yet, don't miss out and join us next Tuesday: t1p.de/d825h
  • Get to this post

    ERN-RND @ern-rnd.bsky.social 5 days

    💻 Upcoming #webinar on “The importance of Genetic Counselling in the Diagnostic of Rare Neurological Disorders”
    📅 9th December, 3:00 CET
    🗣️ Maria Judit Molnar, Semmelweis University, Budapest, Hungary

    Sign up 👉https://t1p.de/d825https://t1p.de/d825htps://bsky.app/hashtag/webinar">#webinar and
  • Get to this post

    ERN-RND @ern-rnd.bsky.social 5 days

    💻 Upcoming #webinar on “Fluid Biomarkers in Frontotemporal Dementia”
    📅 2nd December, 3:00 CET
    🗣️ Domenico Plantone, AOU - University Hospital Siena, Italy

    Sign up 👉https://t1p.de/9hsbhttps://t1p.de/9hsbctps://bsky.app/hashtag/webinar">#webinar and

Find us on Facebook

ERN-RND European Reference Network for Rare Neurological Diseases

Our mission

ERN-RND aims to support rare neurological patients in Europe in getting a timely and appropriate diagnosis, treatment and care.

ERNs

ERN-RND is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. For more information about the ERNs and the EU Health strategy, please visit https://ec.europa.eu/health/ern_en

  • Facebook
  • LinkedIn
  • Bluesky
  • YouTube

Sitemap | Disclaimer and Data Protection

We serve cookies on this site to analyse traffic, remember your preferences, and optimise your experience.